加载中
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
前收盘价
US$166.41
+US$1.12 · +0.68%
盘后
US$166.41
US$0.00 · 0.00%
10月7日 19:30 ET
盘中时间采用ET。市场数据可能有所延迟。
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
日内区间
当前US$166.41
52周区间
当前US$166.41
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
55
合理估值
情绪
51
多空交织
风险
22
中等风险
动量
46
中性
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
日内区间
当前US$166.41
52周区间
当前US$166.41
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 10.37亿 USD | 9.54亿 USD | 9.22亿 USD | 9.42亿 USD | 7.99亿 USD |
| 销货成本 | 6.67亿 USD | 6.17亿 USD | 6.2亿 USD | 6.62亿 USD | 5.56亿 USD |
| 毛利 | 3.71亿 USD | 3.36亿 USD | 3.02亿 USD | 2.8亿 USD | 2.43亿 USD |
| 研究与开发 | 1851万 USD | 1679.3万 USD | 1504.9万 USD | 1219.1万 USD | 1352.4万 USD |
| 销售、一般及管理费用 | 1.43亿 USD | 1.37亿 USD | 1.3亿 USD | 1.23亿 USD | 1.02亿 USD |
| 营业费用 | 1.52亿 USD | 1.53亿 USD | 1.43亿 USD | 1.35亿 USD | 1.16亿 USD |
| 利息支出 | 1021.9万 USD | 1652.8万 USD | 2261.3万 USD | 1026.8万 USD | 245.6万 USD |
| 折旧和摊销 | 4569万 USD | 4797.3万 USD | 5493.5万 USD | 5184.8万 USD | 4887.9万 USD |
| 营业利润 | 2.18亿 USD | 1.83亿 USD | 1.59亿 USD | 1.45亿 USD | 1.28亿 USD |
| 净利润 | 1.55亿 USD | 1.28亿 USD | 1.09亿 USD | 1.05亿 USD | 9610.4万 USD |
公司数据更新于 2026年10月8日。
近期已公布业绩
近期已公布业绩
| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2010年1月21日 | 3:2 | — | — |
股票拆分 | 2007年1月22日 | 3:2 | — | — |
股票拆分 | 2006年1月23日 | 3:2 | — | — |
股票拆分 | 2005年1月21日 | 3:2 | — | — |
股票拆分 | 1998年6月4日 | 3:2 | — | — |
股票拆分 | 1994年10月4日 | 3:2 | — | — |
已生效 2010年1月21日
3:2
已生效 2007年1月22日
3:2
已生效 2006年1月23日
3:2
已生效 2005年1月21日
3:2
已生效 1998年6月4日
3:2
已生效 1994年10月4日
3:2
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1.8亿0.01%2.3万亿 USD0.03%US$381.03-0.40%
iShares Russell 2000 ETFIWM1.4亿0.18%785.63亿 USD0.19%US$277.7-1.29%
Vanguard Morningstar Small-Cap ETFVB1.3亿0.07%1853亿 USD0.03%US$286.98-1.41%
First Trust SMID Cap Rising Dividend Achievers ETFSDVY9461.99万0.86%110.06亿 USD0.58%US$40.90-1.49%
Vanguard Morningstar Small-Cap Growth ETFVBK7465.09万0.16%447亿 USD0.05%US$342.24-1.50%
Vanguard Extended Market ETFVXF6560.5万0.07%954亿 USD0.05%US$233.49-1.56%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM4836.82万0.30%160.11亿 USD0.03%US$53.28-1.32%
iShares Russell 2000 Growth ETFIWO4797.48万0.34%142.49亿 USD0.24%US$355.37-1.43%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBFirst Trust SMID Cap Rising Dividend Achievers ETFSDVYVanguard Morningstar Small-Cap Growth ETFVBKVanguard Extended Market ETFVXFState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMiShares Russell 2000 Growth ETFIWOAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
